ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,242.42
-0.78%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Recursion Pharmaceuticals Inc (RXRX)

  7. Recursion Pharmaceuticals Inc (RXRX) News

RXRX Recursion Pharmaceuticals Inc

8.12
0.28 (3.57%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Recursion Pharmaceuticals Inc RXRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.28 3.57% 8.12 09:55:54
Open Price Low Price High Price Close Price Previous Close
7.86 7.68 8.1391 8.12 7.84
more quote information »

Recent News

Date Time Source Heading
16/4/202422:00GLOBERecursion Appoints Najat Khan, PhD, as Chief R&D Officer and..
02/4/202423:00GLOBERecursion to Participate in Upcoming Investor Conference
26/3/202423:00GLOBERecursion Publishes Annual Environmental, Social and..
11/3/202419:00GLOBERecursion Announces Plans to Open New Office in London
09/3/202411:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202410:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202409:39EDGAR2Form 144 - Report of proposed sale of securities
07/3/202408:59EDGAR2Form 144 - Report of proposed sale of securities
06/3/202408:18EDGAR2Form 144 - Report of proposed sale of securities
02/3/202406:58GLOBERecursion Hosts Second Annual Rare Disease Day Events for..
01/3/202423:59GLOBERecursion to Participate in Upcoming Investor Conferences
01/3/202400:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202408:05GLOBERecursion Provides Business Updates and Reports Fourth..
24/2/202411:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202410:13EDGAR2Form 144 - Report of proposed sale of securities
22/2/202409:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202408:29EDGAR2Form 144 - Report of proposed sale of securities
20/2/202423:59GLOBERecursion to Host Public L(earnings) Call on February 27
17/2/202411:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202411:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202411:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202408:50EDGAR2Form 144 - Report of proposed sale of securities
14/2/202411:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202411:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202410:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:18EDGAR2Form 144 - Report of proposed sale of securities
13/2/202404:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202409:13EDGAR2Form 144 - Report of proposed sale of securities
08/2/202408:56EDGAR2Form 8-K - Current report
07/2/202408:12EDGAR2Form 144 - Report of proposed sale of securities
01/2/202408:40EDGAR2Form 8-K - Current report
30/1/202410:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202408:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/1/202410:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:23EDGAR2Form 144 - Report of proposed sale of securities
25/1/202401:00GLOBEAltitude Lab Startups Raise Over $120M in Capital
24/1/202408:20EDGAR2Form 144 - Report of proposed sale of securities
19/1/202410:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202408:34EDGAR2Form 144 - Report of proposed sale of securities
17/1/202408:14EDGAR2Form 144 - Report of proposed sale of securities
17/1/202401:55EDGAR2Form 144 - Report of proposed sale of securities
12/1/202410:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202409:02EDGAR2Form 144 - Report of proposed sale of securities
10/1/202408:15EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

NASDAQ
RXRX
Recursion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved